Financial Results for December 31, 2015
Concord Drugs Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 201519-02-2016
19-02-2016
Board Intimation for Results & Closure of Trading Window
Concord Drugs Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on February 13, 2016, inter alia, to consider the following:1. Un-audited financial results for the quarter ended December 31, 2015.2. Limited Review Report for the Quarter ended December 31, 2015.Further, as per the Company's internal Code for Prevention of Insider Trading (as amended) the trading window for dealing in...02-02-2016
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
Concord Drugs Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.21-01-2016
Authorised KMPs to determine materiality of events/information
Concord Drugs Ltd has informed BSE regarding "Authorised Key Managerial Personnel to determine materiality of events/information".20-01-2016
Financial Results & Limited Review Report for Sept 30, 2015 (Standalone)
Concord Drugs Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report for the period ended September 30,2015.14-11-2015
Board Intimation for Results & Closure of Trading Window
Concord Drugs Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on November 14, 2015, inter alia, to consider the following:1. Unaudited financial results for the quarter and year ended September 30, 2015.2. Limited Review report for the quarter ended September 30, 2015.Further, as per the Companys internal Code for Prevention of Insider Trading (as amended) the trading window for...02-11-2015
Outcome of AGM
Concord Drugs Ltd has informed BSE that the 20th Annual General Meeting (AGM) of the Company was held on September 30, 2015.01-10-2015
Rectification on Financial Results for June 30, 2015
Concord Drugs Ltd has submitted to BSE a copy of Rectified Financial Results (With Denomination) for the period ended June 30, 2015.11-09-2015
Fixes Book Closure for AGM
Concord Drugs Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 26, 2015 to September 30, 2015 (both days inclusive) for the purpose of Annual General Meeting (AGM) of the Company to be held on September 30, 2015.01-09-2015
Financial Results & Limited Review Report for June 30, 2015 (Standalone)
Concord Drugs Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report for the period ended June 30, 2015.14-08-2015